| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,268,249 |
|
|
|
Indirect Value
|
$149,961,660 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$151,229,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-12-16 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
90,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-01-14 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
90,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-02-14 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
158,124 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
OE |
$7.30 |
$1,313,442 |
D/D |
180,000 |
595,550 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-03-16 |
4 |
OE |
$16.40 |
$1,364,900 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-02-14 |
4 |
OE |
$7.40 |
$1,371,366 |
D/D |
136,488 |
655,069 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-05-06 |
4 |
OE |
$7.41 |
$1,381,305 |
D/D |
186,504 |
634,686 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-04-15 |
4 |
OE |
$20.74 |
$1,451,800 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-14 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-04-14 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-05-14 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-06-16 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-05-15 |
4 |
OE |
$20.74 |
$1,493,550 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-06-15 |
4 |
OE |
$21.58 |
$1,510,250 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-07-15 |
4 |
OE |
$21.58 |
$1,510,250 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-12-15 |
4 |
OE |
$19.09 |
$1,539,562 |
D/D |
70,000 |
197,936 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-08-17 |
4 |
OE |
$21.58 |
$1,550,750 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-04-30 |
4 |
S |
$52.02 |
$1,562,329 |
I/I |
(30,000) |
119,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-07-24 |
4 |
S |
$52.15 |
$1,564,356 |
I/I |
(30,000) |
89,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-05-21 |
4 |
OE |
$16.01 |
$1,601,000 |
D/D |
100,000 |
1,190,125 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-05-17 |
4 |
OE |
$16.44 |
$1,643,750 |
D/D |
100,000 |
618,581 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-09-15 |
4 |
OE |
$23.60 |
$1,652,000 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-10-15 |
4 |
OE |
$23.60 |
$1,652,248 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-11-16 |
4 |
OE |
$23.76 |
$1,662,850 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-10-26 |
4 |
OE |
$8.94 |
$1,788,500 |
D/D |
200,000 |
1,251,553 |
0 |
- |
|
193 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
